List of redirects
Jump to navigation
Jump to search
Showing below up to 50 results in range #6,011 to #6,060.
- BACH → Bach
- BACiiM → Bacitracin
- BAER → Auditory brainstem response
- BAI2 → Brain-specific angiogenesis inhibitor 2
- BAL → Bronchoalveolar lavage
- BALCO → Bay Area Laboratory Co-operative
- BALT → MALT lymphoma
- BANF → Neurofibromatosis type II
- BARC → Bleeding Academic Research Consortium
- BARI → Bypass Angioplasty Revascularization Investigation
- BARI 2D → Bypass Angioplasty Revascularization Investigation In Type 2 Diabetics
- BARS → Beaumont Alcohol Restenosis Study
- BASC → Blood Pressure In Acute Stroke Collaboration
- BASEL → Brain Natriuretic Peptide For Acute Shortness Of Breath Evaluation: A Randomized Comparison
- BASIS → Basel Antiarrhythmic Study Of Infarct Survival
- BASKET → Basel Stent Cost-Effectiveness Trial
- BASKET LATE → Late Clinical Events Related To Late Stent Thrombosis After Stopping Clopidogrel
- BAT → Bivalirudin Angioplasty Study
- BATMAN → Biodivysio 'Bat'Imastat Sv Stent Versus Balloon Angioplasty For The Reduction Of Restenosis In Small Coronary Arteries
- BAV → Atrioventricular block
- BAX → Bcl-2-associated X protein
- BBB → Bundle branch block
- BBC ONE → British Bifurcation Coronary Study: Old, New, And Evolving Strategies
- BBS → Bardet-Biedl syndrome
- BBS—Cognitive Study → Best Bypass Surgery—Cognitive Study
- BCAPS → Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study
- BCC → Basal cell carcinoma
- BCD → Bietti's crystalline dystrophy
- BCL-2 → Bcl-2
- BCL10 gene → BCL10
- BCNU → Carmustine (patient information)
- BCPT → Breast Cancer Prevention Trial
- BCR → Antibody
- BCoV → Bovine coronavirus
- BDCA-2 → CLEC4C
- BDCA-3 → Thrombomodulin
- BDCA-4 → Neuropilin
- BDNF → Brain-derived neurotrophic factor
- BDZ → Benzodiazepine
- BEACH → Boston Scientific Epi: A Carotid Stenting Trial For High-Risk Surgical Patients
- BEACOPP → BEACOPP regimen
- BEAT → Bucindolol Evaluation In Acute Myocardial Infarction Trial
- BEAUTIFUL → Morbidity-Mortality Evaluation Of The If Inhibitor Ivabradine In Patients With Coronary Disease And Left-Ventricular Dysfunction
- BEAUTIFUL study fails to meet primary endpoint but demonstrates that heart rates can safely be reduced with Ivabradine → Special:Badtitle/NS100:BEAUTIFUL study fails to meet primary endpoint but demonstrates that heart rates can safely be reduced with Ivabradine
- BECAIT → Bezafibrate Coronary Atherosclerosis Intervention Trial
- BED → Binge eating disorder
- BELLES → Beyond Endorsed Lipid Lowering With Ebt Scanning
- BELVIQ → Lorcaserin
- BEN → Balkan nephropathy
- BENEDICT → Bergamo Nephrologic Diabetes Complications Tria